Publications by authors named "Juntima Sritabal"
Article Synopsis
- Severe falciparum malaria causes red blood cells infected with the parasite to stick to blood vessel walls and other red cells, obstructing blood flow in critical organs.
- Heparin can help reverse this adhesion but has a risk of bleeding, while sevuparin aims to maintain the anti-adhesive benefits without significant anticoagulant effects.
- Research shows that sevuparin effectively disrupts rosette formation and inhibits the adherence of infected red blood cells to vascular cells, suggesting it could be a useful addition to standard malaria treatments.
The antimalarial susceptibility of ring stage (> 80%) Plasmodium vivax from the Republic of Korea, where long incubation-period strains are prevalent, was evaluated using the schizont maturation inhibition technique. During 2005-2007, susceptibility to seven antimalarial drugs was evaluated with 24 fresh isolates. The geometric mean (95% confidence interval) 50% inhibition concentration (IC(50)) were quinine 60 (54-75) ng/mL, chloroquine 39 (22-282) ng/mL, piperaquine 27 (17-58) ng/mL, mefloquine 39 (35-67) ng/mL, pyrimethamine 138 (89-280) ng/mL, artesunate 0.
View Article and Find Full Text PDFThe relationship of the platelet-mediated autoagglutination of Plasmodium falciparum-infected red blood cells (IRBCs) to disease severity was investigated in 182 Thai patients with falciparum malaria; it was evident in 43% of uncomplicated malaria (n=63), 41% of severe malaria (n=104), and 100% of cerebral malaria (n=15; P=.001) isolates. The median (range) number of IRBCs in agglutinates per 1000 IRBCs was significantly higher in cerebral malaria (6 [3-42]) than in severe (0 [0-52]) and uncomplicated (0 [0-24]) malaria (P=.
View Article and Find Full Text PDF